181 related articles for article (PubMed ID: 2038384)
1. [Exacerbation of psoriasis caused by malaria prophylaxis with chloroquine and proguanil].
Damstra RJ; van Vloten WA
Ned Tijdschr Geneeskd; 1991 Apr; 135(15):671-3. PubMed ID: 2038384
[TBL] [Abstract][Full Text] [Related]
2. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
[TBL] [Abstract][Full Text] [Related]
4. [Pharmaceutical care for international voyagers: prophylaxis including chloroquine plus proguanil].
Hernández Tintorer JL; Lorduy Osés L
Farm Hosp; 2004; 28(2):137-40. PubMed ID: 15101806
[TBL] [Abstract][Full Text] [Related]
5. [Severe psoriasis induced by chloroquine (nivaquine)].
Nicolas JF; Mauduit G; Haond J; Chouvet B; Thivolet J
Ann Dermatol Venereol; 1988; 115(3):289-93. PubMed ID: 2970239
[TBL] [Abstract][Full Text] [Related]
6. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
Wolters BA; Bosje T; Luinstra-Passchier MJ
Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
[TBL] [Abstract][Full Text] [Related]
7. [Adverse effects associated with antimalarial chemoprophylaxis].
Corominas N; Gascón J; Mejías T; Caparrós F; Quintó L; Codina C; Ribas J; Corachán M
Med Clin (Barc); 1997 May; 108(20):772-5. PubMed ID: 9265081
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of chloroquine-proguanil malaria prophylaxis in a non-immune population in Bangui, Central African Republic: a case-control study.
Matsika-Claquin MD; Ménard D; Fontanet AL; Ngwhotue A; Sarda J; Talarmin A
Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):381-6. PubMed ID: 16313935
[TBL] [Abstract][Full Text] [Related]
9. Malaria deaths following inappropriate malaria chemoprophylaxis--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(28):597-9. PubMed ID: 11476528
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
Overbosch D; Schilthuis H; Bienzle U; Behrens RH; Kain KC; Clarke PD; Toovey S; Knobloch J; Nothdurft HD; Shaw D; Roskell NS; Chulay JD;
Clin Infect Dis; 2001 Oct; 33(7):1015-21. PubMed ID: 11528574
[TBL] [Abstract][Full Text] [Related]
11. Effect of antimalarial drugs on psoriasis.
Kuflik EG
Cutis; 1980 Aug; 26(2):153-5. PubMed ID: 6447575
[TBL] [Abstract][Full Text] [Related]
12. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
[TBL] [Abstract][Full Text] [Related]
13. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
Carme B; Péguet C; Nevez G
Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
[TBL] [Abstract][Full Text] [Related]
14. The Italian army standpoint on malaria chemoprophylaxis.
Peragallo MS
Med Trop (Mars); 2001; 61(1):59-62. PubMed ID: 11584658
[TBL] [Abstract][Full Text] [Related]
15. Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.
Pang LW; Limsomwong N; Singharaj P; Canfield CJ
Bull World Health Organ; 1989; 67(1):51-8. PubMed ID: 2706727
[TBL] [Abstract][Full Text] [Related]
16. Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups.
Mutabingwa TK; Eling WM; Kitinya JN; Malle LN; de Geus A
Trop Geogr Med; 1993; 45(6):274-9. PubMed ID: 8116057
[TBL] [Abstract][Full Text] [Related]
17. Chemoprophylaxis of malaria: underlying principles and their realization.
Wernsdorfer WH
Med Trop (Mars); 1990; 50(1):119-24. PubMed ID: 2195278
[TBL] [Abstract][Full Text] [Related]
18. Malaria chemosuppression in pregnancy. II. Its effect on maternal haemoglobin levels, placental malaria and birth weight.
Mutabingwa TK; Malle LN; de Geus A; Oosting J
Trop Geogr Med; 1993; 45(2):49-55. PubMed ID: 8511810
[TBL] [Abstract][Full Text] [Related]
19. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
[TBL] [Abstract][Full Text] [Related]
20. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
Lundgren JD; Dragsted UB
Ugeskr Laeger; 2000 Jul; 162(31):4177-81. PubMed ID: 10962933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
